Back to School: How biopharma can reboot drug development. Access exclusive analysis here
IMNR and partner Agouron (La Jolla, Calif.), a subsidiary of Warner-Lambert (WLA), began a Phase III trial of IMNR's
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury